Innovation Forum
The EUFOREA Innovation Forum is a new type of virtual event that will offer balanced debates featuring multidisciplinary stakeholders including medical scientists, physicians, patients, payers and healthcare industry representatives on topics related to innovation.
Watch below the latest Innovation Forum Debates.
- All Posts
- Airway Diseases
- Algorithms
- Allergen Immunotherapy/AIT
- Allergic Rhinitis/AR
- Anaphylaxis
- Asthma
- Atopic Dermatitis
- Biologics
- Chronic Respiratory Diseases/CRD
- Chronic Rhinosinusitis/CRS
- COPD
- COVID-19
- CRSwNP
- CRSwNP Awareness Day
- Debates
- Educational
- EPOS
- EUFOREA News
- Events
- Health Professionals
- Inhalers
- Innovation Forum
- Nasal
- Nasal Polyps/NP
- Nose
- On-Demand Series
- Paediatric
- Patient Advisory Board
- Patients
- Pocket Guides
- Publications
- Respiratory Future Debates
- Rhinology
- Rhinology Future Debates
- Rhinoplasty
- Sinus Surgery
- Smell Loss
- Symptoms
- Testimonials
- Treatments
- Type 2 Inflammation
- Webinars
Allergic rhinitis is a highly prevalent disease – an inflammatory disorder of the nasal lining caused by a reaction to various allergens. In addition, it’s…
The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution of care, considering the improved knowledge…
#LetsTalkCRS In 2022 EUFOREA launched its first Global Rhinosinusitis with Nasal Polyps Awareness Day, as part of a broader strategy to raise awareness of this…
CRS with Nasal Polyps – Setting the new gold standardFor decades, surgery of the nose and paranasal sinuses has been the gold standard for treating…
Asthma, Chronic Rhinosinusitis with Nasal Polyps or CRSwNP and Atopic Dermatitis are three chronic conditions that often co-exist in patients. They can cause a myriad…
Separating facts from fictionWhat do Lockdowns, Self-isolation, Flattening the Curve, and Social Distancing have in common? Let’s find out! On 9 December, we were joined…